via University of Notre Dame
There is only one marketed antibiotic for MRSA that can be taken orally
A team of University of Notre Dame researchers led by Mayland Chang and Shahriar Mobashery have discovered a new class of antibiotics to fight bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and other drug-resistant bacteria that threaten public health. Their research is published in the Journal of the American Chemical Society in an article titled “Discovery of a New Class of Non-beta-lactam Inhibitors of Penicillin-Binding Proteins with Gram-Positive Antibacterial Activity.”
The new class, called oxadiazoles, was discovered in silico (by computer) screening and has shown promise in the treatment of MRSA in mouse models of infection. Researchers who screened 1.2 million compounds found that the oxadiazole inhibits a penicillin-binding protein, PBP2a, and the biosynthesis of the cell wall that enables MRSA to resist other drugs. The oxadiazoles are also effective when taken orally. This is an important feature as there is only one marketed antibiotic for MRSA that can be taken orally.
MRSA has become a global public-health problem since the 1960s because of its resistance to antibiotics. In the United States alone, 278,000 people are hospitalized and 19,000 die each year from infections caused by MRSA. Only three drugs currently are effective treatments, and resistance to each of those drugs already exists.
The researchers have been seeking a solution to MRSA for years. “Professor Mobashery has been working on the mechanisms of resistance in MRSA for a very long time,” Chang said. “As we understand what the mechanisms are, we can devise strategies to develop compounds against MRSA.”
“Mayland Chang and Shahriar Mobashery’s discovery of a class of compounds that combat drug resistant bacteria such as MRSA could save thousands of lives around the world. We are grateful for their leadership and persistence in fighting drug resistance,” said Greg Crawford, dean of the College of Science at the University of Notre Dame.
The Latest on: Antibiotics
via Google News
The Latest on: Antibiotics
- Scientists suggest a new approach to mitigating the collateral damage from antibioticson October 13, 2021 at 7:21 pm
Antibiotics help us to treat bacterial infections and save millions of lives each year. But they can also harm the helpful microbes residing in our gut, weakening one of our body's first lines of ...
- Tackling the collateral damage from antibioticson October 13, 2021 at 8:10 am
Antibiotics help us to get rid of bacterial infections – but they can also harm the helpful microbes residing in our guts. Researchers from the Typas group at EMBL Heidelberg and collaborators have ...
- Some antibiotics may kill 'helpful' gut bacteria, study findson October 13, 2021 at 8:01 am
Tetracyclines and macrolides, two commonly used classes of antibiotics, stop beneficial gut bacteria from growing and ultimately kill them, a study published Wednesday by Nature found.
- Study probes link between antibiotics during pregnancy and allergieson October 13, 2021 at 1:46 am
Doctors are investigating whether increased use of antibiotics during pregnancy and childbirth could be contributing to the rise in allergies ...
- Does a 2-Day Course of Antibiotics Lower the Incidence of Ventilator-associated Pneumoniaon October 13, 2021 at 1:35 am
The purpose of this double-blind, randomized control trial was to see if a 2-day course of amoxicillin-clavulanate could reduce the incidence of early ventilator-associated pneumonia in patients ...
- Conversations in the Cath Lab: Do You Use Antibiotics?on October 12, 2021 at 12:05 pm
When—if ever—are antibiotics warranted before vascular closure devices are used? Turns out, opinions are mixed.
- Cardboard cuttings, no antibiotics and food on the floor: Nature Strip’s different Everest prepon October 12, 2021 at 10:25 am
Trainer Chris Waler says Nature Strip’s hay fever problem is now behind him as his coat has the winning sheen heading into The Everest.
- Proteon Pharma to focus on development of Bacteriophages as a sustainable alternative to antibiotics in poultry industryon October 12, 2021 at 7:00 am
Proteon Pharmaceuticals India - a subsidiary of Proteon Pharmaceuticals SA Poland, today announced it will focus on the development of bacteriophages as a sustainable alternative to ...
- Study: Antibiotics can't save children from stunted growth in developing worldon October 7, 2021 at 6:54 am
Antibiotics alone likely cannot overcome the complex factors that cause stunted growth and perpetuate the cycle of poverty in the developing world, new research suggests.
- Inhaled Antibiotics Market Report 2021 Size with Segments Analysis, Competitive Landscape, Top Countries Data and Growth Opportunities to 2027on October 4, 2021 at 11:06 pm
Global “Inhaled Antibiotics Market” Size, Status and Growth Forecast to 2027: The Inhaled Antibiotics Market report ...
via Bing News
